Fri, May 20, 2022

Esther Hong Downgraded (SPRO) to Hold and Held Target at $2 on, May 20th, 2022

Esther Hong of Berenberg, Downgraded "Spero Therapeutics, Inc." (SPRO) to Hold and Held Target at $2 on, May 20th, 2022.

Esther has made no other calls on SPRO in the last 4 months.



There are 4 other peers that have a rating on SPRO. Out of the 4 peers that are also analyzing SPRO, 2 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $2 on, Wednesday, May 4th, 2022
  • Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, May 4th, 2022


These are the ratings of the 2 analyists that currently disagree with Esther


  • Louise Chen of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $5 on, Tuesday, May 17th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Monday, April 18th, 2022